ETFs with PharmaCyte Biotech (PMCB) Exposure
The following ETFs maintain exposure to PharmaCyte Biotech (PMCB). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
1 ETF Hold PharmaCyte Biotech (PMCB)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in PMCB |
|---|---|---|---|---|---|---|
| VXF | Vanguard Extended Market ETF | $30.86B | 0.05% | <0.01% | $23.31K | 0.53% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in PMCB |
|---|---|---|---|---|---|---|
| VXF | <0.01% | Vanguard Extended Market ETF | $30.86B | 0.05% | $23.31K | 0.53% |
Popular ETF Comparisons
PMCB ETF Exposure FAQ
What ETFs hold PharmaCyte Biotech stock?
PharmaCyte Biotech (PMCB) is currently held by 1 ETF in TipRanks’ ETF exposure database. The ETF(s) with exposure to PMCB include Vanguard (VXF).
Which ETF has the largest exposure to PMCB?
The ETF with the largest exposure to PMCB is Vanguard (VXF), with approximately $23.31K in market value exposure.
How much PMCB stock is held by ETFs?
ETFs currently hold approximately $23.31K worth of PharmaCyte Biotech (PMCB) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.